Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BackgroundThe potential for HIV transmission between a pregnant woman and her unborn child was first recognized in 1982. Since then a complex package of measures to reduce risk has been developed. This project aims to review UK management of HIV in pregnancy as part of the British HIV Association (BHIVA) audit programme.MethodsThe National Study of HIV in Pregnancy and Childhood (NSHPC), a population-based surveillance study, provided data for pregnancies with an expected delivery date from 1/1/13 - 30/6/14. Services also completed a survey on local management policies. Data were audited against the 2012 BHIVA pregnancy guidelines.ResultsDuring the audit period 1483 pregnancies were reported and 112 services completed the survey. Use of dedicated multidisciplinary teams was reported by 99% although 26% included neither a specialist midwife nor nurse. 17% of services reported delays >1 week for HIV specialist review of women diagnosed antenatally. Problematic urgent HIV testing had been experienced by 9% of services although in a further 49% the need for urgent testing had not arisen. Delays of >2 h in obtaining urgent results were common. Antiretroviral therapy (ART) was started during pregnancy in 37% women with >94% regimens in accordance with guidelines. Late ART initiation was common, particularly in those with a low CD4 count or high viral load. Eleven percent of services reported local policy contrary to guidelines regarding delivery mode for women with a VL <50 copies/mL at ≥36 weeks. According to NSHPC reports 27% of women virologically eligible for vaginal delivery planned to deliver by CS.ConclusionsPregnant women in the UK are managed largely in accordance with BHIVA guidelines. Improvements are needed to ensure timely referral and ART initiation to ensure the best possible outcomes.

Original publication

DOI

10.1186/s12879-017-2255-6

Type

Journal article

Journal

BMC infectious diseases

Publication Date

20/02/2017

Volume

17

Addresses

British HIV Association, London, UK. sonia.raffe@bsuh.nhs.uk.

Keywords

British HIV Association Audit and Standards Sub-Committee, Humans, Pregnancy Complications, Infectious, HIV Infections, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Perinatal Care, Prenatal Care, Cesarean Section, Pregnancy, Adolescent, Adult, Middle Aged, Guideline Adherence, Female, Practice Guidelines as Topic, Clinical Audit, Infectious Disease Transmission, Vertical, Young Adult, Public Health Surveillance, Practice Patterns, Nurses', Practice Patterns, Physicians', United Kingdom